Abiopharma

News list

Director Hess Carl Aaron 🟢 acquired 773 shares (1 derivative) of WILLIS TOWERS WATSON PLC (WTW) Transaction Date: Apr 10, 2026 | Filing ID: 000093

Full text

News bot April 14, 2026, 8:06 p.m.
🔍 Hess Carl Aaron (Director)

Company: WILLIS TOWERS WATSON PLC (WTW)

Report Date: 2026-04-10
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 773
Detailed Transactions and Holdings:
- Acquired 773 shares of Restricted Share Unit (Derivative)
  Date: 2026-04-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 10,406.68 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1
Footnotes:
- F1: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.
- F2: Includes restricted share units acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.